Prudential Financial Inc Meridian Bioscience Inc Transaction History

Prudential Financial Inc

$65.9 Billion
Q2 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$31.15 - $33.39 $16,384 - $17,563	-526 Reduced 1.1%	47,233 $0
Q3 2022 Nov 04, 2022	SELL	$30.9 - $33.55 $354,423 - $384,818	-11,470 Reduced 19.37%	47,759 $1.52 Million
Q2 2022 Aug 15, 2022	SELL	$23.75 - $31.69 $201,946 - $269,460	-8,503 Reduced 12.55%	59,229 $1.8 Million
Q1 2022 May 13, 2022	SELL	$19.97 - $26.94 $266,220 - $359,137	-13,331 Reduced 16.45%	67,732 $1.76 Million
Q4 2021 Feb 14, 2022	SELL	$17.46 - $21.61 $984,988 - $1.22 Million	-56,414 Reduced 41.04%	81,063 $1.65 Million
Q3 2021 Nov 15, 2021	SELL	$17.35 - $22.5 $6.43 Million - $8.34 Million	-370,545 Reduced 72.94%	137,477 $2.65 Million
Q2 2021 Aug 16, 2021	SELL	$18.01 - $28.32 $1.3 Million - $2.04 Million	-71,917 Reduced 12.4%	508,022 $11.3 Million
Q1 2021 May 12, 2021	SELL	$19.76 - $29.89 $5.14 Million - $7.78 Million	-260,326 Reduced 30.98%	579,939 $15.2 Million
Q4 2020 Feb 16, 2021	SELL	$15.73 - $21.66 $434,619 - $598,465	-27,630 Reduced 3.18%	840,265 $15.7 Million
Q3 2020 Nov 16, 2020	BUY	$13.54 - $26.41 $2.07 Million - $4.04 Million	153,074 Added 21.41%	867,895 $14.7 Million
Q2 2020 Aug 12, 2020	BUY	$7.84 - $23.29 $5.08 Million - $15.1 Million	648,316 Added 974.84%	714,821 $16.6 Million
Q1 2020 May 12, 2020	SELL	$5.57 - $11.5 $7,346 - $15,168	-1,319 Reduced 1.94%	66,505 $558,000
Q4 2019 Feb 11, 2020	SELL	$7.9 - $10.14 $23,660 - $30,369	-2,995 Reduced 4.23%	67,824 $662,000
Q3 2019 Nov 13, 2019	SELL	$9.17 - $12.01 $122,923 - $160,994	-13,405 Reduced 15.92%	70,819 $672,000
Q2 2019 Aug 08, 2019	BUY	$10.88 - $17.6 $36,328 - $58,766	3,339 Added 4.13%	84,224 $0
Q1 2019 May 15, 2019	SELL	$15.51 - $17.61 $8,235 - $9,350	-531 Reduced 0.65%	80,885 $0
Q4 2018 Feb 07, 2019	SELL	$14.52 - $19.72 $465,569 - $632,302	-32,064 Reduced 28.26%	81,416 $1.41 Million
Q3 2018 Nov 07, 2018	SELL	$14.85 - $16.35 $1.96 Million - $2.16 Million	-132,050 Reduced 53.78%	113,480 $0
Q2 2018 Aug 13, 2018	SELL	$13.8 - $16.8 $1.98 Million - $2.41 Million	-143,646 Reduced 36.91%	245,530 $0
Q1 2018 May 04, 2018	BUY	$13.8 - $16.2 $178,737 - $209,822	12,952 Added 3.44%	389,176 $0
Q4 2017 Feb 13, 2018	BUY	$13.55 - $15.8 $596,389 - $695,421	44,014 Added 13.25%	376,224 $5.27 Million
Q3 2017 Nov 02, 2017	BUY	$13.45 - $14.35 $4.47 Million - $4.77 Million	332,210	332,210 $4.75 Million

Others Institutions Holding VIVO

# of Institutions

Shares Held

113K

Call Options Held

Put Options Held

View Full List

About MERIDIAN BIOSCIENCE INC

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

More about VIVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prudential Financial Inc with notifications on news.

Account